UNSPSC 51183108: Glypinamide

This classification denotes an anti-diabetic agent with the molecular formula C13H18ClN3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) ORE084U8IP, chemically known as urea, 1-((p-chlorophenyl)sulfonyl)-3-(hexahydro-1h-azepin-1-yl)- but more generally known as glypinamide, which bears US NIH Compound Identifier 219111. European Medicines Agency schedules Glypinamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07956MIG.

UNSPSC 51183108 Glypinamide is a Commodity code that covers the procurement of this active pharmaceutical ingredient by state and local health authorities and correctional facilities. State and local governments purchase glypinamide primarily through health departments managing chronic disease programs, correctional health services supplying medication to incarcerated populations, and state-run or contracted pharmacy benefit managers. The work involves sourcing and supplying the chemical compound itself rather than finished dosage forms, positioning it as a specialized input for institutional pharmaceutical manufacturing or compounding operations where state and local agencies maintain their own formulation capacity or partner with contracted manufacturers.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB notices identifying specific issuing bodies, response dates, or geographic activity, no characterization of issuing-body concentration, regional spread, or representative solicitations can be drawn from current market data.